King Wealth Management Group’s Gilead Sciences GILD Stock Holding History

King Wealth Management Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$240K	Buy	1,725 +41	+2%	+$5.74K	0.03%	143
2025 Q4	$207K	Sell	1,684 -428	-20%	-$52K	0.02%	155
2025 Q3	$234K	Buy	2,112 +1	+0%	+$114	0.03%	149
2025 Q2	$234K	Buy	2,111 +1	+0%	+$106	0.03%	145
2025 Q1	$236K	Buy	+2,110	New	+$218K	0.04%	136
2020 Q3	–	Sell	-2,704	Closed	-$208K	–	162
2020 Q2	$208K	Buy	2,704 +4	+0.1%	+$307	0.06%	143
2020 Q1	$202K	Sell	2,700 -32,030	-92%	-$2.21M	0.09%	126
2019 Q4	$2.26M	Sell	34,730 -596	-2%	-$38.8K	0.6%	32
2019 Q3	$2.24M	Buy	35,326 +5,780	+20%	+$378K	0.64%	31
2019 Q2	$2M	Sell	29,546 -3,030	-9%	-$199K	0.6%	31
2019 Q1	$2.12M	Buy	32,576 +18,365	+129%	+$1.22M	0.66%	32
2018 Q4	$889K	Buy	+14,211	New	+$993K	0.32%	49

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

King Wealth Management Group's GILD Position: Q1 2026 in Review

King Wealth Management Group increased its Gilead Sciences (GILD) stake by 2.4% in Q1 2026, buying an estimated $5.74K and bringing the position to 1,725 shares worth $240K. The position accounts for 0.03% of the portfolio, ranked #143.

King Wealth Management Group first reported a position in GILD in Q4 2018 and has held it in 12 quarters since. The position peaked at $2.26M in Q4 2019. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

King Wealth Management Group held 1,725 shares of Gilead Sciences worth $240K as of Q1 2026.
King Wealth Management Group bought 41 Gilead Sciences shares in Q1 2026, an estimated $5.74K.
Gilead Sciences made up 0.03% of King Wealth Management Group's portfolio in Q1 2026, its #143 holding.
King Wealth Management Group first reported a position in Gilead Sciences in Q4 2018 and has held it in 12 quarters since.
King Wealth Management Group's Gilead Sciences position peaked at $2.26M in Q4 2019.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on King Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.